×
About 535 results

ALLMedicine™ Superior Vena Cava Syndrome Center

Research & Reviews  203 results

Leadless pacemakers as a new alternative for pacemaker lead-related superior vena cava ...
https://doi.org/10.1111/pace.14520
Pacing and Clinical Electrophysiology : PACE; Curnis A, Milidoni A et. al.

May 18th, 2022 - Superior vena cava (SVC) syndrome is a rare disease induced by thrombosis and consequent occlusion of superior vena cava, negatively affecting morbidity and mortality. The incidence of SVC syndrome from central venous catheters and pacemaker or de...

Intraoperative Collateral Drainage Evaluation Before Superior Caval Interruption in Par...
https://doi.org/10.1177/15569845221097790
Innovations (Philadelphia, Pa.); Affronti A, Sandoval E et. al.

May 14th, 2022 - A superior sinus venosus atrial septal defect and partial anomalous pulmonary venous connection was corrected by a minimally invasive approach by permanently ligating the superior vena cava and a single pericardial patch for rerouting the flow thr...

Mediastinal Lymphoma
https://emedicine.medscape.com/article/203681-overview

May 4th, 2022 - Practice Essentials Primary mediastinal B-cell lymphoma (PMBCL) is relatively rare B-cell non-Hodgkin lymphoma that comprises 6–12% of all diffuse large B-cell lymphomas (DLBCLs) and 2–4% of all non-Hodgkin lymphomas. PMBCL affects young adults in...

Direct Oral Anticoagulant for a Right Atrial Thrombus Following Endovascular Stenting i...
https://doi.org/10.1253/circj.CJ-22-0055
Circulation Journal : Official Journal of the Japanese Ci... Akazawa Y, Higaki T et. al.

Apr 5th, 2022 - Direct Oral Anticoagulant for a Right Atrial Thrombus Following Endovascular Stenting in Superior Vena Cava Syndrome.|2022|Akazawa Y,Higaki T,Inaba S,Yamaguchi O,|

Successful Chemotherapy With Early Leadless Pacemaker Implantation for a Giant Malignan...
https://doi.org/10.1253/circj.CJ-22-0071
Circulation Journal : Official Journal of the Japanese Ci... Hirano F, Okamura A et. al.

Apr 1st, 2022 - Successful Chemotherapy With Early Leadless Pacemaker Implantation for a Giant Malignant Lymphoma Complicated by Unstable Atrioventricular Block and Superior Vena Cava Syndrome.|2022|Hirano F,Okamura A,Kato M,Ogura K,Tomomori T,|

see more →

News  11 results

Novel Molecular Targets for Drug Development in Non-GIST Sarcomas
https://www.onclive.com/view/novel-molecular-targets-for-drug-development-in-non-gist-sarcomas

Dec 20th, 2020 - William D. Tap, MD Abstract The characterization of molecular abnormalities implicated in the tumorigenesis of sarcomas is being increasingly applied to the classification, prognostication and, in particular situations, management of these ...

Untreated Goiters Larger at Surgery in Men, Minorities, and the Old
https://www.staging.medscape.com/viewarticle/860299

Mar 14th, 2016 - Significant disparities exist in the presentation and outcomes of patients with goiters in the United States, with minority ethnic groups, men, and older patients more likely to present with untreated goiters that have become so large they extend ...

David Henry's JCSO podcast, November 2014
https://www.mdedge.com/hematology-oncology/article/89098/follicular-lymphoma/david-henrys-jcso-podcast-november-2014
Dr. David Henry

Nov 30th, 2014 - Among the items featured in Dr David Henry’s monthly podcast for The Journal of Community and Supportive Oncology, are reports on congestive heart failure during induction with anthracycline-based therapy in patients with acute promyelocytic leuke.

Study identified predictors of ICU survival in lung cancer patients
https://www.mdedge.com/hematology-oncology/article/86501/lung-cancer/study-identified-predictors-icu-survival-lung-cancer
Amy Karon

Aug 15th, 2014 - Intensive care units can provide meaningful survival for patients with lung cancer who have good performance status and nonrecurrent disease, even if they have severe complications such as sepsis or multiple organ failure, authors of a multicenter.

ASTRO Says Few Cancers Qualify for Proton Therapy
https://www.medpagetoday.com/radiology/therapeuticradiology/46170

Jun 4th, 2014 - Evidence to support reimbursement for proton-beam therapy remains limited to several relatively uncommon cancers, although some patients enrolled in clinical trials also should receive coverage consideration, according to the American Society for ...

see more →